Cargando…
Development of omics‐based protocols for the microbiological characterization of multi‐strain formulations marketed as probiotics: the case of VSL#3
The growing commercial interest in multi‐strain formulations marketed as probiotics has not been accompanied by an equal increase in the evaluation of quality levels of these biotechnological products. The multi‐strain product VSL#3 was used as a model to setup a microbiological characterization tha...
Autores principales: | Mora, Diego, Filardi, Rossella, Arioli, Stefania, Boeren, Sjef, Aalvink, Steven, de Vos, Willem M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801179/ https://www.ncbi.nlm.nih.gov/pubmed/31402586 http://dx.doi.org/10.1111/1751-7915.13476 |
Ejemplares similares
-
Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3
por: Douillard, François P., et al.
Publicado: (2018) -
Correction: Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3
por: Douillard, François P., et al.
Publicado: (2018) -
Characterization of antibiotic-resistance traits in Akkermansia muciniphila strains of human origin
por: Filardi, Rossella, et al.
Publicado: (2022) -
The Neglected Microbial Components of Commercial Probiotic Formulations
por: Fiore, Walter, et al.
Publicado: (2020) -
Comparison of Microbiological, Histological, and Immunomodulatory Parameters in Response to Treatment with Either Combination Therapy with Prednisone and Metronidazole or Probiotic VSL#3 Strains in Dogs with Idiopathic Inflammatory Bowel Disease
por: Rossi, Giacomo, et al.
Publicado: (2014)